首页> 美国政府科技报告 >Evaluation of Chemotherapeutic Agents Against Malaria; Drugs, Diet, andBiological Response Modifiers
【24h】

Evaluation of Chemotherapeutic Agents Against Malaria; Drugs, Diet, andBiological Response Modifiers

机译:评估抗疟疾的化疗药物;药物,饮食和生物反应调节剂

获取原文

摘要

In the primary blood schizonticidal test 1,043 compounds were evaluated and 186exhibited antimalarial activity. In the Thompson Test 41 experiments were performed to access suppressive and curative activity against drug-sensitive lines or lines resistant to chloroquine, mefloquine, halofantrine, quinine, WR238605, pyrimethamine, tetraoxane (WR163577), and WR99210. Twenty-two transdermal tests were performed with several artemisinin analogs. Dihydroartemisinin was the most active compound. Louderback's Sterilizing Medium was tested against drug-sensitive parasites and artemisinin-resistant ones. Special tests with trioxanes, beta-artemether, and trifluralin were done. Sixteen antioxidant experiments were done, which included testing wR238605 and tetraoxane (BM11681) in mice primed for oxidative stress. Mice were cured of cerebral malaria by altering the oxidative status of the hosts RBC's. Surviving mice were rechallenged to evaluate the curative activity of drugs.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号